# New clinical trials in Romania: 409 since Nov 2024

Updated November 9, 2026.

409 clinical studies with a site in Romania were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 280 have an industry sponsor and 272 are recruiting or about to. The newest, NCT07927088, was posted on November 9, 2026: Halova Vaginal Ovules Versus Placebo for Genitourinary Symptoms in Premenopausal Women (Perfect Care Distribution).

## The full list

New clinical trials with a site in Romania: 409 rows for $20.45, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 10 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/country/romania

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 409
- Industry sponsored: 280
- Recruiting or not yet: 272
- Latest posted: November 9, 2026

## Newest trials

The newest 100 of 409, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07927088 | Halova Vaginal Ovules Versus Placebo for Genitourinary Symptoms in Premenopausal Women | Perfect Care Distribution | Not applicable | Completed | Vaginal Dryness, Genitourinary Symptoms | 150 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927088) |
| November 9, 2026 | NCT07924540 | Endoscopic Ultrasound Shear Wave Elastography in Solid Pancreatic Lesions | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | Not applicable | Completed | Pancreatic Cancer, Solid Pancreatic Mass Lesions, Pancreatic Adenocarcinoma | 62 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924540) |
| November 4, 2026 | NCT07916155 | Effects of Virtual Reality Exergaming on Reaction Time, Physical Performance, and Muscle Activity in Children | Babes-Bolyai University | Not applicable | Not yet recruiting | Neuromuscular Performance, Reaction Time, Postural Balance | 360 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916155) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| October 30, 2026 | NCT07907224 | Characterization of Small Intestinal Bacterial Overgrowth and Intestinal Barrier-Related Biomarkers in Patients With Severe Periodontitis | Iuliu Hatieganu University of Medicine and Pharmacy | Observational | Recruiting | Periodontitis (Stage 3), Periodontitis Stage IV, SIBO | 20 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907224) |
| October 30, 2026 | NCT07906223 | Evolution of Gait Parameters in Toddlers With Unilateral Cerebral Palsy | National Clinical Center for Neuropsychomotor Recovery for Children Dr. Nicolae Robanescu | Observational | Completed | Unilateral Cerebral Palsy | 78 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906223) |
| October 28, 2026 | NCT07902141 | A Web-based Intervention Program for Postpartum Depression | Babes-Bolyai University | Early phase 1 | Recruiting | Postpartum Depression (PPD), Web-based Intervention | 30 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902141) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 23, 2026 | NCT07891806 | REM Sleep Disruption and Its Potential Uses in Depression Management | WAKEZ HEALTH TECH ECOSYSTEM SRL | Not applicable | Completed | Depression / Major Depressive Disorder, Depressed Mood | 208 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891806) |
| October 23, 2026 | NCT07891247 | Complementary Exercise-Based Therapy for Obstructive Sleep Apnea | bioROne | Not applicable | Completed | Obstructive Sleep Apnea | 24 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891247) |
| October 21, 2026 | NCT07885891 | Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia | Wockhardt | Phase 3 | Not yet recruiting | Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | 324 | Bosnia and Herzegovina, Bulgaria, Croatia, France, Georgia, Greece, India... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885891) |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | Brazil, China, Germany, Japan, Puerto Rico, Romania, South Korea, Spain... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881458) |
| October 19, 2026 | NCT07881133 | Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery | Bucharest Emergency Hospital | Not applicable | Recruiting | Colorectal (Colon or Rectal) Cancer, STOMACH NEOPLASM | 320 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881133) |
| October 16, 2026 | NCT07878858 | Equivalence of Systolic Blood Pressure Measurements Between Fowler and Seated Positions | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Not yet recruiting | Blood Pressure Measurement | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878858) |
| October 16, 2026 | NCT07878767 | Pilot Study: Evaluation of the Safety of the Application of Non-thermal HIFU for Varicose Veins Treatment of the Lower Limbs | VeinSound | Not applicable | Recruiting | Superficial Venous Insufficiency, Varicose Veins | 15 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878767) |
| October 15, 2026 | NCT07875582 | Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma | Grigore T. Popa University of Medicine and Pharmacy | Observational | Recruiting | Pancreatic Cancer, Chronic Pancreatitis, Intraductal Papillary Mucinous Neoplasm, Mucinous Cystic Neoplasm | 100 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875582) |
| October 14, 2026 | NCT07874373 | Magnesium Supplementation for the Prevention of Cisplatin-Induced Nephrotoxicity | Grigore T. Popa University of Medicine and Pharmacy | Not applicable | Completed | Cisplatin-induced Nephrotoxicity | 43 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874373) |
| October 13, 2026 | NCT07871214 | A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage... | Bristol-Myers Squibb | Phase 2 | Not yet recruiting | Early-Stage Non-Small Cell Lung Cancer | 80 | Australia, Canada, China, France, Germany, Italy, Japan, Poland, Romania, South... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871214) |
| October 13, 2026 | NCT07870850 | Clinical Outcomes in Patients Presenting With Acute Variceal Bleeding | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | Observational | Completed | Portal Hypertension Related to Cirrhosis, Variceal Bleeding, Cirrhoses, Liver | 149 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07870850) |
| September 30, 2026 | NCT07850453 | Vortosiran for VTE Prevention | Ribocure Pharmaceuticals AB | Phase 2 | Not yet recruiting | Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis) | 150 | Bulgaria, France, Poland, Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850453) |
| September 29, 2026 | NCT07845487 | A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis | Palisade Bio | Phase 2 | Recruiting | Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis | 204 | Canada, Czechia, France, Georgia, Hungary, Italy, Latvia, Poland, Romania... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845487) |
| September 17, 2026 | NCT07825948 | AI-Personalized Digital Exercise for University Students | Transilvania University of Brasov | Not applicable | Completed | Physical Activity, Exercise Adherence, Wellbeing | 299 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825948) |
| September 17, 2026 | NCT07825168 | Telerehabilitation in Patients With Peripheral Arterial Disease | Grigore T. Popa University of Medicine and Pharmacy | Not applicable | Completed | Peripheral Arterial Disease | 42 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825168) |
| September 16, 2026 | NCT07821554 | Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma | Inna Chen, MD | Not applicable | Not yet recruiting | Pancreatic Cancer | 250 | Denmark, Italy, Norway, Romania, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821554) |
| September 10, 2026 | NCT07813312 | AI-Supported Digital Coaching And Cardiorespiratory Fitness In Male University Students | Transilvania University of Brasov | Not applicable | Completed | Physical Activity, Cardiorespiratory Fitness | 312 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07813312) |
| August 27, 2026 | NCT07789015 | A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Idiopathic Inflammatory Myopathies | 270 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789015) |
| August 25, 2026 | NCT07786220 | Cognitive Load and Inhaler Technique in COPD | Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara | Not applicable | Recruiting | COPD | 100 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786220) |
| August 17, 2026 | NCT07768189 | A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma | Corbus Pharmaceuticals Inc. | Phase 3 | Recruiting | Oropharyngeal Carcinoma (OPC) | 260 | Austria, Belgium, Canada, France, Germany, Hungary, Italy, Portugal, Romania... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768189) |
| August 13, 2026 | NCT07762027 | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection | Assembly Biosciences | Phase 2 | Not yet recruiting | Chronic Hepatitis D Infection | 80 | France, Georgia, Germany, Italy, Moldova, New Zealand, Pakistan, Romania... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762027) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 12, 2026 | NCT07759505 | Efficacy and Tolerability Evaluation of a Novel Dermo-cosmetic Product for Mild-to-moderate Acne | ISISPHARMA | Observational | Completed | Acne Vulgaris | 90 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759505) |
| August 12, 2026 | NCT07759245 | A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) | Eli Lilly and Company | Phase 2 | Recruiting | Pulmonary Disease, Chronic Obstructive | 606 | Argentina, Austria, Canada, China, Czechia, Denmark, France, Germany, Hungary... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759245) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| August 7, 2026 | NCT07753213 | Beat Saber Exergaming and Isometric Strength in Youth Basketball Players | Babes-Bolyai University | Not applicable | Completed | No Disease | 80 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753213) |
| July 29, 2026 | NCT07734922 | High-Intensity Laser Therapy and Physiotherapy for Bone Health in Postmenopausal Women: A Randomized Trial | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Not yet recruiting | Osteoporosis, Postmenopausal, Osteopenia | 40 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07734922) |
| July 28, 2026 | NCT07731412 | Short-Term Changes in Salivary IL-6, TNF-α, and Periodontal Inflammation Following Sleeve Gastrectomy in Patients With Obesity: A... | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Not applicable | Completed | Obesity, Periodontitis | 32 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731412) |
| July 28, 2026 | NCT07731126 | New Care Pathways for Supporting TRANSitional CARE From Hospital to Home Using AI and Personalized Digital Assistance | Istituto Nazionale di Ricovero e Cura per Anziani | Not applicable | Recruiting | Transitional Care, Remote Patient Monitoring (RPM), Geriatric Multimorbidity | 210 | Italy, Norway, Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731126) |
| July 22, 2026 | NCT07719673 | Enteral Nutrition and Colonization Resistance Through Microbiota Modulation in Critically Ill Patients | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Not yet recruiting | Bacterial Colonization, Multidrug Resistant Organisms, Critical Illness, Gut Microbiota Dysbiosis | 60 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07719673) |
| July 13, 2026 | NCT07697469 | Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization | Grigore T. Popa University of Medicine and Pharmacy | Observational | Not yet recruiting | Cardiovascular-Kidney-Metabolic Syndrome, Atrial Cardiomyopathy, Atrial Fibrillation, Chronic Kidney Disease, Metabolic... | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697469) |
| July 9, 2026 | NCT07691970 | Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From... | AstraZeneca | Phase 3 | Recruiting | Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus | 1,072 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691970) |
| July 7, 2026 | NCT07687784 | A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia | AFT Pharmaceuticals, Ltd. | Phase 3 | Not yet recruiting | Iron Deficiency Anemia (IDA) | 1,366 | Bulgaria, Poland, Romania, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687784) |
| July 7, 2026 | NCT07686263 | Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | Phase 3 | Recruiting | Schizophrenia | 472 | Argentina, Bulgaria, Czechia, Poland, Romania, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686263) |
| July 2, 2026 | NCT07680764 | A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy... | Bristol-Myers Squibb | Phase 2 | Recruiting | Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC) | 160 | Argentina, Australia, Brazil, Chile, China, France, Germany, Italy, Romania... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680764) |
| June 30, 2026 | NCT07676786 | Euvolemia-Based Assessment of Pulmonary Hypertension in Stable Hemodialysis Patients | Stefan Lujinschi | Observational | Not yet recruiting | Pulmonary Hypertension (PH), End Stage Kidney Disease (ESRD), Hemodialysis Patients, Volume Overload, Volume... | 30 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07676786) |
| June 25, 2026 | NCT07669285 | Platelet-Rich Plasma Versus Standard Care for Episiotomy Wound Healing in Postpartum Women | Saint Andrew Hospital Constanta | Not applicable | Not yet recruiting | Episiotomy, Platelet Rich Plasma (PRP), Wound Healing, Obstetric | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669285) |
| June 25, 2026 | NCT07668388 | A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes | Novo Nordisk A/S | Phase 2 | Recruiting | Diabetes Mellitus, Type 2 | 300 | Australia, Germany, Hungary, Poland, Romania, Slovakia, South Korea, Spain... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668388) |
| June 22, 2026 | NCT07660809 | Comparison of Patient-Reported Comfort Between Two Clear Aligner Trimming-Line Designs: A Split-Mouth Study | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Observational | Completed | Patient Comfort, Malocclusion, Oral Health | 70 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07660809) |
| June 18, 2026 | NCT07657897 | The Impact of Anaesthesia and Sedation on Inflammation and NETosis in Hepatocellular Carcinoma Ablation | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Recruiting | Hepato Cellular Carcinoma (HCC), Sedation and Analgesia, Ablation Techniques | 100 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07657897) |
| June 17, 2026 | NCT07653048 | Personality Traits and Biochemical Risk Phenotypes | Medical Center TOPMED | Observational | Recruiting | Prediabetes, Hyperglycemia, Metabolic Syndrome | 1,000 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653048) |
| June 17, 2026 | NCT07652502 | Physical Exercise During the Cancer Care Pathway | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Observational | Not yet recruiting | Cancer, Treatment-Related, Cancer, Oncology, Oncologic Disorders | 370 | France, Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652502) |
| June 17, 2026 | NCT07652294 | Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD | Spyre Therapeutics, Inc. | Phase 2 | Enrolling by invitation | Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative | 645 | Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652294) |
| June 11, 2026 | NCT07642037 | Marginal Biofilm Distribution and Periodontal Response to Supragingival and Juxtagingival Aligner Designs | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Not applicable | Completed | Periodontal Diseases, Dental Plaque, Gingivitis | 20 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07642037) |
| June 10, 2026 | NCT07638306 | Internal Jugular Vein Ultrasound and Acute Kidney Injury After Abdominal Surgery | Tîrgu Mureș Emergency Clinical County Hospital, Romania | Observational | Recruiting | Intraoperative Hypotension, Jugular Veins, Hypotension on Induction, General Anesthesia With Propofol | 150 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07638306) |
| June 5, 2026 | NCT07628491 | Effect of Finishing Clear Aligner Marginal Termination Design (Supragingival vs Juxtagingival) on Aligner Color Stability After 14 Days of... | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Not applicable | Completed | Malocclusion, Esthetics, Dental | 50 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628491) |
| June 3, 2026 | NCT07624305 | A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) | AstraZeneca | Phase 3 | Recruiting | Renal Insufficiency, Chronic | 2,800 | Argentina, Austria, Brazil, Bulgaria, Canada, China, France, Germany, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624305) |
| June 3, 2026 | NCT07623161 | A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib | Takeda | Phase 3 | Recruiting | Myelofibrosis, Anemia | 324 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623161) |
| May 22, 2026 | NCT07604480 | Remimazolam-Propofol Combination Sedation for Gastrointestinal Endoscopy: A Prospective Observational Study | University of Medicine and Pharmacy "Victor Babes" Timisoara | Observational | Completed | Procedural Sedation, Gastrointestinal Endoscopy | 29 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07604480) |
| May 22, 2026 | NCT07604376 | Comparative Analysis of the Impact of Transversus Abdominis Plane Block on Post-Cesarean Pain Management Using Low Concentration... | Matild Keresztes | Not applicable | Recruiting | Postoperative Pain, Postoperative Acute Pain | 70 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07604376) |
| May 22, 2026 | NCT07603726 | Multimodal Intervention for GGT Reduction in Alcohol Use Disorder (GGT-AUD) | Medical Center TOPMED | Not applicable | Completed | Alcohol Use Disorder (AUD) | 197 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07603726) |
| May 22, 2026 | NCT07602088 | A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic... | Janssen Research & Development, LLC | Observational | Recruiting | Leukemia, Lymphocytic, Chronic, B-Cell | 60 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602088) |
| May 19, 2026 | NCT07596849 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease. | argenx | Phase 3 | Recruiting | Graves Disease | 230 | Belgium, Bulgaria, Canada, Denmark, Georgia, Germany, Greece, Italy, Japan... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07596849) |
| May 15, 2026 | NCT07589114 | REM Enhancement Sleep Technology for Well-being, Emotion, and Life Lift | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Not applicable | Not yet recruiting | Healthy Adult Participants | 150 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07589114) |
| May 13, 2026 | NCT07582783 | A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania | Janssen Research & Development, LLC | Observational | Recruiting | Psoriasis | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582783) |
| May 11, 2026 | NCT07577856 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis | Janssen Research & Development, LLC | Phase 3 | Recruiting | Colitis, Ulcerative | 644 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577856) |
| May 11, 2026 | NCT07577843 | A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease | Janssen Research & Development, LLC | Phase 3 | Recruiting | Crohn Disease | 460 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577843) |
| May 8, 2026 | NCT07575347 | Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) | Stefan Lujinschi | Observational | Recruiting | Periodontal Disease, Periodontitis, CKD, Chronic Kidney Disease, Alport Syndrome, Fabry Disease, Lupus or SLE, Tuberous... | 100 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575347) |
| May 4, 2026 | NCT07564414 | A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or... | Novo Nordisk A/S | Phase 3 | Recruiting | Obesity, Type 2 Diabetes | 2,500 | Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07564414) |
| May 1, 2026 | NCT07562152 | Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma | Immuneering Corporation | Phase 3 | Recruiting | Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal... | 570 | Australia, Georgia, Germany, Hungary, Poland, Romania, Spain, United Kingdom... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562152) |
| May 1, 2026 | NCT07561749 | SER-ABS-AUD: Neuropsychosocial-Spiritual Correlates of Serene Abstinence in Adults With AUD | Grigore T. Popa University of Medicine and Pharmacy | Observational | Enrolling by invitation | Alcohol Use Disorder (AUD), Alcohol Abstinence | 70 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07561749) |
| April 30, 2026 | NCT07558980 | Platelet-Rich Plasma Composition and Clinical Effects in Knee Osteoarthritis | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Completed | Knee Arthritis, Osteoarthritis | 40 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07558980) |
| April 27, 2026 | NCT07551830 | Process-Based Psychological Processes in Alcohol Use Disorder: A Case-Control Study Using PBAT, PHQ-9, and GAD-7 | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Observational | Not yet recruiting | Alcohol Use Disorder (AUD) | 200 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07551830) |
| April 24, 2026 | NCT07550543 | PEMF Therapy in Shoulder Tendinopathy | Balnear and Rehabilitation Sanatorium Techirghiol | Not applicable | Completed | Shoulder Tendinopathy | 83 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07550543) |
| April 23, 2026 | NCT07547540 | A Study of LY3971297 in Participants With Heart Failure | Eli Lilly and Company | Phase 1 | Recruiting | Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic | 90 | Japan, Moldova, Netherlands, Romania, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07547540) |
| April 20, 2026 | NCT07540221 | A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating... | Grifols Therapeutics LLC | Phase 3 | Recruiting | CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) | 40 | Czechia, Poland, Romania, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540221) |
| April 17, 2026 | NCT07537595 | Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) \[400-450nm\] | Cosmetique Active International | Observational | Completed | Skin Pigmentation, Healthy Volunteers, Hyperpigmentation | 33 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537595) |
| April 16, 2026 | NCT07533955 | A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis | Jade Biosciences, Inc. | Phase 1 | Recruiting | Rhematoid Arthritis | 36 | Bulgaria, Georgia, Germany, Moldova, Romania, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533955) |
| April 16, 2026 | NCT07533175 | AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose... | Novo Nordisk A/S | Phase 3 | Active not recruiting | Diabetes Mellitus, Overweight, Obesity | 638 | Argentina, Brazil, Croatia, Hungary, Italy, Mexico, Romania, Slovakia, South... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533175) |
| April 16, 2026 | NCT07533058 | Influence of Finishing Clear Aligner Marginal Termination Design on Subgingival Periodontal Microbiota During Orthodontic Treatment: A... | George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | Not applicable | Completed | Periodontal Diseases, Malocclusion, Oral Health | 36 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533058) |
| April 13, 2026 | NCT07526805 | Digital Manufacturing and Periodontal Performance of CAD/CAM-Customized Orthodontic Molar Bands Compared With Standard Stainless-Steel Bands | Dimitrie Cantemir University | Not applicable | Completed | Orthodontic Appliances, Adverse Effects,Gingivitis, Dental Plaque, Periodontal Diseases | 180 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526805) |
| April 8, 2026 | NCT07517315 | Expanded Access to Vodobatinib for Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Who Have Not Responded to... | Sun Pharma Advanced Research Company Limited | Not applicable | Temporarily not available | CML, Relapsed, CML, Refractory | Not listed | France, Hungary, India, Italy, Romania, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517315) |
| April 8, 2026 | NCT07517263 | An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen... | Novartis Pharmaceuticals | Phase 3 | Active not recruiting | Cardiovascular Disease and Lipoprotein(a) | 5,700 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517263) |
| April 3, 2026 | NCT07509320 | This Systematic Review Aims to Synthesize Available Evidence Regarding the Prevalence, Anatomical Distribution, Etiological Determinants... | Dimitrie Cantemir University | Observational | Withdrawn | Tooth Impaction, Impacted Canine, Dental Anomalies | 0 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07509320) |
| March 31, 2026 | NCT07504458 | Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia | Quetzal Therapeutics | Phase 3 | Recruiting | Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute... | 150 | France, Italy, Romania, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07504458) |
| March 27, 2026 | NCT07497087 | A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Boehringer Ingelheim | Phase 3 | Recruiting | Systemic Sclerosis | 448 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497087) |
| March 25, 2026 | NCT07493304 | Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers | Regeneron Pharmaceuticals | Phase 3 | Recruiting | Venous Thromboembolism (VTE) | 1,600 | Bulgaria, Japan, Romania, South Korea, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07493304) |
| March 25, 2026 | NCT07491848 | Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D | Research Center of Periodontal-Systemic Interactions | Observational | Recruiting | HEPATITIS B CHRONIC, Hepatitis D, Periodontitis | 25 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07491848) |
| March 17, 2026 | NCT07476729 | International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) | Charite University, Berlin, Germany | Phase 3 | Recruiting | B-Cell Acute Lymphoblastic Leukaemia | 750 | Austria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476729) |
| March 17, 2026 | NCT07476326 | Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma | Biocon Biologics UK PLC | Phase 1 | Recruiting | Melanoma | 120 | Brazil, Chile, Georgia, Moldova, Romania, Serbia, South Africa, Spain, Turkey... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476326) |
| March 16, 2026 | NCT07475299 | Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome | Iuliu Hatieganu University of Medicine and Pharmacy | Not applicable | Not yet recruiting | Irritable Bowel Syndrome (IBS) | 8 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475299) |
| March 16, 2026 | NCT07473700 | Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease | Tectonic Operating Company, Inc. | Phase 2 | Recruiting | Hypertension, Pulmonary, Lung Diseases, Interstitial | 25 | Poland, Romania, Serbia, South Korea, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07473700) |
| March 16, 2026 | NCT07472517 | DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and... | Boehringer Ingelheim | Phase 3 | Recruiting | Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC) | 670 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472517) |
| March 16, 2026 | NCT07472283 | Design, Development and Evaluation of a Digital Health Assistant for Paediatric Asthma | University Children's Hospital Basel | Observational | Not yet recruiting | Paediatric Asthma | 42 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472283) |
| March 12, 2026 | NCT07465679 | A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With... | Novartis Pharmaceuticals | Observational | Completed | Heart Failure With Reduced Ejection Fraction | 2,508 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07465679) |
| March 10, 2026 | NCT07462117 | Comparison of Nd Yag, Diode and Er:YAG Lasers vs Scalpel in Preprosthetic Vestibuloplasty: Vestibular Depth Gain | University of Medicine and Pharmacy "Victor Babes" Timisoara | Not applicable | Completed | Edentulous; Alveolar Process, Atrophy, Healthy Adult Participants, Edentulous Alveolar Ridge With Labial Resorption | 36 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07462117) |
| March 6, 2026 | NCT07454837 | Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide | Mirum Pharmaceuticals, Inc. | Phase 2/3 | Recruiting | Chronic Hepatitis D | 120 | Austria, Czechia, France, Germany, Italy, Romania, Spain, United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07454837) |
| March 3, 2026 | NCT07444931 | Validation of Sudden Cardiac Arrest Risk Factors in Patients With CAD | Tampere Heart Hospital | Observational | Recruiting | Coronary Arterial Disease (CAD), Sudden Cardiac Arrest, Sudden Cardiac Death | 1,500 | Israel, Moldova, Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444931) |
| March 2, 2026 | NCT07442552 | Perioperative Sepsis. An Epigenetic Perspective | Carol Davila University of Medicine and Pharmacy | Observational | Recruiting | Sepsis Abdominal | 40 | Romania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07442552) |
| March 2, 2026 | NCT07441876 | Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia | BioMarin Pharmaceutical | Phase 2/3 | Recruiting | Achondroplasia | 160 | Australia, Canada, Italy, Japan, Poland, Romania, South Korea, United Kingdom... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07441876) |
| March 2, 2026 | NCT07441642 | A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related... | Novartis Pharmaceuticals | Phase 2 | Recruiting | Geographic Atrophy Secondary to Age-related Macular Degeneration | 272 | Argentina, Australia, Brazil, Bulgaria, Canada, China, Colombia, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07441642) |
| February 27, 2026 | NCT07438496 | A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | Janssen Research & Development, LLC | Phase 3 | Recruiting | Lupus Erythematosus, Systemic | 600 | Argentina, Australia, Brazil, Bulgaria, China, Czechia, Denmark, Finland... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07438496) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Bristol-Myers Squibb | 27 | October 13, 2026 |
| Eli Lilly and Company | 16 | October 28, 2026 |
| Boehringer Ingelheim | 13 | November 4, 2026 |
| Babes-Bolyai University | 12 | November 4, 2026 |
| Iuliu Hatieganu University of Medicine and Pharmacy | 12 | October 30, 2026 |
| Grigore T. Popa University of Medicine and Pharmacy | 12 | October 15, 2026 |
| Janssen Research & Development, LLC | 12 | May 22, 2026 |
| AstraZeneca | 11 | August 12, 2026 |
| George Emil Palade University of Medicine, Pharmacy, Sciences and Technology of Targu Mures | 9 | July 28, 2026 |
| Novartis Pharmaceuticals | 9 | April 8, 2026 |
| Merck Sharp & Dohme LLC | 9 | January 23, 2026 |
| Novo Nordisk A/S | 8 | June 25, 2026 |
| University of Medicine and Pharmacy "Victor Babes" Timisoara | 5 | May 22, 2026 |
| argenx | 5 | May 19, 2026 |
| Neurocrine Biosciences | 5 | December 17, 2025 |
| AbbVie | 5 | November 13, 2025 |
| GlaxoSmithKline | 5 | October 21, 2025 |
| Sanofi | 5 | September 24, 2025 |
| Immunovant Sciences GmbH | 5 | September 23, 2025 |
| Hoffmann-La Roche | 4 | January 20, 2026 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Carcinoma, Non-Small-Cell Lung](https://specstream.ai/data/clinical-trials/condition/carcinoma-non-small-cell-lung) | 22 | October 13, 2026 |
| [Obesity](https://specstream.ai/data/clinical-trials/condition/obesity) | 20 | October 28, 2026 |
| [Overweight](https://specstream.ai/data/clinical-trials/condition/overweight) | 16 | October 28, 2026 |
| [Neoplasms](https://specstream.ai/data/clinical-trials/condition/neoplasms) | 13 | September 30, 2026 |
| [Colitis, Ulcerative](https://specstream.ai/data/clinical-trials/condition/colitis-ulcerative) | 10 | September 29, 2026 |
| [Pulmonary Disease, Chronic Obstructive](https://specstream.ai/data/clinical-trials/condition/pulmonary-disease-chronic-obstructive) | 10 | August 25, 2026 |
| [Lung Neoplasms](https://specstream.ai/data/clinical-trials/condition/lung-neoplasms) | 10 | December 16, 2025 |
| [Diabetes Mellitus, Type 2](https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-2) | 9 | October 28, 2026 |
| [Depression](https://specstream.ai/data/clinical-trials/condition/depression) | 9 | October 23, 2026 |
| [Lupus Erythematosus, Systemic](https://specstream.ai/data/clinical-trials/condition/lupus-erythematosus-systemic) | 9 | May 8, 2026 |
| [Renal Insufficiency, Chronic](https://specstream.ai/data/clinical-trials/condition/renal-insufficiency-chronic) | 8 | August 10, 2026 |
| [Heart Failure](https://specstream.ai/data/clinical-trials/condition/heart-failure) | 7 | August 12, 2026 |
| [Autoimmune Diseases](https://specstream.ai/data/clinical-trials/condition/autoimmune-diseases) | 7 | September 23, 2025 |
| [Depressive Disorder, Major](https://specstream.ai/data/clinical-trials/condition/depressive-disorder-major) | 6 | October 23, 2026 |
| [Schizophrenia](https://specstream.ai/data/clinical-trials/condition/schizophrenia) | 6 | July 7, 2026 |
| [Neoplasm Metastasis](https://specstream.ai/data/clinical-trials/condition/neoplasm-metastasis) | 6 | May 1, 2026 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 6 | April 20, 2026 |
| [Stroke](https://specstream.ai/data/clinical-trials/condition/stroke) | 6 | April 8, 2026 |
| [Small Cell Lung Carcinoma](https://specstream.ai/data/clinical-trials/condition/small-cell-lung-carcinoma) | 6 | March 16, 2026 |
| [Arthritis, Rheumatoid](https://specstream.ai/data/clinical-trials/condition/arthritis-rheumatoid) | 6 | February 25, 2026 |
| [Alzheimer Disease](https://specstream.ai/data/clinical-trials/condition/alzheimer-disease) | 6 | October 9, 2025 |
| [Pancreatic Neoplasms](https://specstream.ai/data/clinical-trials/condition/pancreatic-neoplasms) | 5 | November 9, 2026 |
| [Cardiovascular Diseases](https://specstream.ai/data/clinical-trials/condition/cardiovascular-diseases) | 5 | October 28, 2026 |
| [Anxiety Disorders](https://specstream.ai/data/clinical-trials/condition/anxiety-disorders) | 5 | April 27, 2026 |
| Hepatitis D | 5 | March 25, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 165 | November 4, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 89 | November 9, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 67 | October 30, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 49 | October 13, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 15 | April 23, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 14 | March 6, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 8 | February 12, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 1 | October 28, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 1 | February 20, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).